Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
By Deena Beasley Dec 12 (Reuters) – Alzheimer’s trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their…
Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer’s trials
By Deena Beasley SAN DIEGO Dec 2 (Reuters) – Novo Nordisk in 2020 launched pivotal trials of its…